Stimulating Excellence

Clinical Advancement

Neuromod Devices’ management team and board include scientific, clinical and industry experts in hearing and tinnitus. The team collaborates with other opinion-leading scientists and clinicians.

Together we design and conduct large-scale clinical trials at internationally recognised sites and publish the results in high-tier peer-reviewed journals, where they are evaluated by independent scientific experts.

Through this process, Neuromod works to build the credibility and establish bimodal neuromodulation as a new standard of care for tinnitus.

Neuromod's bimodal neuromodulation device, Lenire®, has been successful trialled across three large scale clinical trials involving 600+ participants. Trials were conducted at a number of European clinical sites under the guidance and supervision of our Science Advisory Board.

As a result of these trials, Lenire® has been granted a CE-mark in Europe and a FDA De Novo Grant in the United States for the treatment of tinnitus.

Details of clinical trials can be found here:

Phase I – Safety and Feasibility Study:

Phase IIa (TENT-A1 Protocol Paper) – Parameter Optimisation and Patient Subtyping Study

Phase IIa (TENT-A1 Results Paper) – Parameter Optimisation and Patient Subtyping Study

Phase IIb (TENT-A2 Protocol Paper) – Parameter Optimisation and Patient Subtyping Study

Phase IIb (TENT-A2 Results Paper) – Parameter Optimisation and Patient Subtyping Study

Science Advisory Board members

Prof. Berthold Langguth

University of Regensburg

Berthold Langguth is a Consultant Neuropsychiatrist who runs the Department of Psychiatry and Psychosomatic Medicine at Germany’s University of Regensburg Hospital (UHREG), which he has established as a leading European site for clinical trials and tinnitus research.

Prof. Langguth is an international key opinion leader in the field of tinnitus research with over 300 peer-reviewed publications and book chapters. A key focus area of research is patient subtyping and neuromodulation.

Prof. Langguth is the founder of the Tinnitus Research Initiative (TRI), a non-profit organisation that brings together tinnitus scientists from across the globe is dedicated to the development of effective treatments for all types of tinnitus.

Prof. Sven Vanneste

University of Texas

Sven Vanneste is Professor of Neurosciences at Trinity College Dublin (TCD) in Ireland and the University of Texas at Dallas in the USA.

A leading voice in the field of neuromodulation research, with over 250 peer-reviewed publications and book chapters, Prof. Vanneste has established a neuromodulation research laboratory that has become a leading neuromodulation research centre globally.

Prof. Vanneste has collaborated on invasive and non-invasive neuromodulation trials for the Enterprise Ireland, the Health Research, Board, US Department of Defence (US-DoD), the US National Institutes for Health (NIH) and the US Food and Drug Administration (FDA) for neuromodulation start-ups and large medical device multinationals.

Prof. Deborah Hall

Heriot-Watt University Malaysia

Deborah Hall is currently Head of the Department of Psychology at Heriot-Watt University Malaysia where she holds an appointment as Professor of Positive Psychology. Prior to this she led active tinnitus and translational neuroscience research teams at the University of Nottingham, UK and was Deputy Director of the National Institute for Health Research Nottingham Biomedical Research Centre.

In the fields of clinical trial methodologies and evidence-based medicines, Prof. Hall is highly regarded internationally, with over 100 peer-reviewed publications and book chapters. She was awarded the British Society of Audiology Thomas Simm Littler Prize in 2010 for her services to audiology, and is the Editor of ‘Hearing Research’, one of the highest impact factor journals in the world of auditory research.